PLEASANTON, Calif., Feb. 1, 2022 /PRNewswire/ — Veeva Systems (NYSE: VEEV) will announce financial results for its fourth quarter and full fiscal year, which ended January 31, 2022, after market close on March 2, 2022. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results.
Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event.
Event: Veeva’s Fiscal 2022 Fourth Quarter and Full Year Results Conference Call
Date: Wednesday, March 2, 2022
Time: 2:00 p.m. PT (5:00 p.m. ET)
Online Registration: www.directeventreg.com
Conference ID: 86021
Webcast: ir.veeva.com
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Veeva uses its ir.veeva.com website as a means of disclosing material non-public information, announcing upcoming investor conferences, and for complying with its disclosure obligations under Regulation FD. Accordingly, you should monitor Veeva’s investor relations website in addition to following its press releases, SEC filings, and public conference calls and webcasts.
Investor Relations Contact: |
||
Ato Garrett Veeva Systems Inc. 925-271-4204
Media Contact: Maria Scurry |
View original content:https://www.prnewswire.com/news-releases/veeva-to-release-fiscal-2022-fourth-quarter-and-full-year-results-on-march-2-2022-301473046.html
SOURCE Veeva Systems
- Leading efficient care management for the elderly with unimpeded smartcare https://img.hankyung.com/pdsdata/pr.hankyung.com/uploads/2024/11/image01-1.png SEOUL, South Korea, Nov.…
- Attruby is the first and only approved product with aspecifying near-complete stabilization…
PALO ALTO, Calif., Nov. 22, 2024 /PRNewswire/ -- Aulisa® Medical USA, Inc., a leader in…
Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - DEFENCE THERAPEUTICS INC. (CSE: DTC) (OTCQB:…
3,250 InsuJet Starter Packs Being Delivered to Pharmacies Across CanadaToronto, Ontario--(Newsfile Corp. - November 22,…